We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GTM:NASDAQZoomInfo Technologies Inc. Analysis

Data as of 2026-05-22 - not real-time

$3.57

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

ZoomInfo (GTM) is trading far below its historical averages and intrinsic valuation. The stock price of $3.57 sits well under the 20‑day ($5.34), 50‑day ($5.67) and 200‑day ($8.66) SMAs, confirming a bearish price trend, while the RSI of 21.7 signals an oversold condition. Technicals are mixed – the MACD remains bearish and the histogram negative, yet the volume trend is increasing, suggesting accumulating interest at lower levels. On the fundamentals side, GTM trades at a PE of 8.9 versus an industry average of ~39, and a price‑to‑book below 1, while the DCF model estimates a fair value of $12.0, implying roughly 46% upside. However, the company faces heightened risk from a 30‑day volatility of >126%, a beta above 1.5, a historic max drawdown of ~71%, and ongoing shareholder investigations that could weigh on sentiment.
The recent earnings release highlighted modest revenue growth (1.5%) and strategic pricing adjustments, but also noted macro‑headwinds and workforce restructuring. Analyst consensus remains a “hold” with mixed outlooks – some firms have cut ratings to underperform, while others flag the stock as an oversold opportunity. Given the deep discount to intrinsic value, strong cash flow generation, and low dividend yield, the upside potential is compelling, yet the elevated risk profile and legal uncertainties counsel a measured approach.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • RSI indicating oversold conditions
  • Increasing volume despite price weakness
  • Significant upside potential relative to current price

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Undervaluation versus peers and DCF estimate
  • Ongoing shareholder investigations and regulatory scrutiny
  • Stable cash flow but modest revenue growth

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests multi‑digit upside
  • Strong gross and operating margins in a high‑margin SaaS model
  • Strategic AI enhancements to the platform offering long‑term growth

Key Metrics & Analysis

Financial Health

Revenue Growth1.50%
Profit Margin10.10%
P/E Ratio8.9
ROE8.12%
ROA2.72%
Debt/Equity106.56
P/B Ratio0.7
Op. Cash Flow$460.9M
Free Cash Flow$354.8M
Industry P/E39.1

Technical Analysis

TrendBearish
RSI21.7
Support$3.46
Resistance$6.87
MA 20$5.34
MA 50$5.67
MA 200$8.66
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Fair Value$11.99
Target Price$5.22
Upside/Downside46.28%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.57
Volatility126.88%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.